Watch for the New Osteoporosis Med, Romosozumab (Evenity)

You'll see some postmenopausal women admitted on the new osteoporosis med romosozumab (Evenity, ee-VEN-ih-tee).

Romosozumab is an injectable monoclonal antibody that blocks sclerostin, a protein involved in bone metabolism. This leads to increased bone growth AND decreased bone breakdown.

Other osteoporosis meds do one or the other.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote